Catalysts for Purdue Pharma LP
108 tracked
Feb 21, 2003
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Dec 18, 2001
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Feb 12, 2001
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Jun 27, 2000
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 12, 2000
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 2, 2000
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 2, 2000
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 2, 2000
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 2, 2000
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 2, 2000
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Apr 29, 1997
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Nov 8, 1993
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Apr 12, 1990
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Jan 16, 1990
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Sep 12, 1989
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 2, 1988
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Apr 8, 1988
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 29, 1987
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→